Blue Horseshoe Stocks: SVSN Review & More

Stereo Vision Entertainment, Inc. SVSN

It was roughly six weeks back that we put SVSN on our radars on a routine news scan, and as we always say, it’s better to be early to the party than late. All the way up until last week, the stock wasn’t trading with any real vigor, but things have picked in a huge way, both in volume and price.

From its low at .08 at the beginning of last week, the stock finished out at a high of .89, for an intraweek rip of 1012% This came on the news that the company will file a $50M Real Estate Investment Trust on behalf of its CannaVision subsidiary, with the goal of organically growing cannabis for the purposes of extracting CBD.


Progressive Care, Inc. RXMD

We also want to swing back around to RXMD this morning, which we intially tagged onthe morning of February 22nd. Since that time the stock has exhibited a fairly steady climb up the chart.

We observed a low of .0663 in RXMD on that first day, and as of Friday’s new high of .129, we had watched as the stock rose 95% over a period of just seven trading sessions. It’s streaking to its highest PPS in nearly five years, so it’s safe to say RXMD is in blue sky breakout territory, and we’ll be eager to continue tracking its movements.



Fate Therapeutics, Inc. FATE

We also wanted to recap the solid move we’ve witnessed in FATE, since mentioning the stock toward the end of January. It dipped slightly to a low of 6.76 shortly thereafter, and has since gone a very impressive run.

The stock reached a new high of 14.02 on Friday, which worked out to a 108% upswing in a matter of less than a month.


Extended Watchlist:
RJDG, ATNM, INPX, NSPR, GNL, OTIV, CLSD, MYSZ

Blue Horseshoe Stocks: Cannabis News Play & More

Stereo Vision Entertainment SVSN

We had SVSN hit our scanner this morning after we noticed an interesting PR coming across the wires. We’re always looking for new interests in the cannabis space, and SVSN fits that bill. Unlike many of the companies in the business conduct their activities primarily in the western states, SVSN has an operation in Florida.

The company just announced a February 1, 2018 Grand Opening of its majority owned subsidiary CannaVision’s Bay Pines medical cannabis and holistic pain management clinic in St Petersburg, Florida. (>>View PR)

We’ll be interested to track the progress of this new facility, and SVSN stock itself going forward.


SPDR S&P 500 ETF (SPY)

We also want to throw in a quick options idea for the SPY, which despite a momentary hiccup in its week’s-long bullish trend yesterday, looks to be gapping up and ready to get back on track today. There are a set of contracts expiring today that we want to radar: the SPY 01/17 $277.50-279 Calls*.

Please be aware that contracts approaching expiration are subject to evaporating premiums due to time decay, so these are quick-strike opportunities only. We’ll be looking for the classic early dip and rip pattern, which should present those chances for intraday flips.

*Be aware that this idea is extremely high risk, and for advanced level traders only!


Extended Watchlist:
TVPC, DDD, MITK, ADAP, ARGS, IOVA